Related Experiment Video
Updated: May 21, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Autoimmunity, dendritic cells and relevance for Parkinson's disease
E Koutsilieri1, M B Lutz, C Scheller
1Institute of Virology and Immunobiology, University of Würzburg, Versbacher Straße 7, 97078, Würzburg, Germany. eleni.koutsilieri@vim.uni-wuerzburg.de
Journal of Neural Transmission (Vienna, Austria : 1996)
|June 16, 2012
Summary
Parkinson's disease involves immune system activation, including dendritic cells and neuromelanin. This review explores neuroinflammation and autoimmunity in Parkinson's disease pathogenesis.
Area of Science:
- Neuroimmunology
- Neurodegenerative Diseases
- Parkinson's Disease Pathogenesis
Background:
- Immune system involvement in neurodegenerative diseases is a growing research area.
- Parkinson's disease (PD) pathogenesis remains incompletely understood, with emerging evidence implicating immune mechanisms.
- Activated microglia and T-cell infiltration are recognized contributors to PD.
Purpose of the Study:
- To review the role of dendritic cells in initiating autoimmune responses in Parkinson's disease.
- To discuss neuroinflammation and autoimmunity in the context of PD.
- To present new evidence linking neuromelanin to these processes.
Main Methods:
- Literature review focusing on neuroinflammation, autoimmunity, dendritic cells, and neuromelanin in Parkinson's disease.
- Synthesis of current research on immune system involvement in PD pathogenesis.
Main Results:
- Dendritic cells play a key role in initiating autoimmune responses relevant to PD.
- Neuroinflammation and autoimmune mechanisms are increasingly recognized in PD.
- Neuromelanin is implicated as a potential factor in PD-related immune processes.
Conclusions:
- The immune system, particularly dendritic cells and neuromelanin, is significantly involved in Parkinson's disease.
- Understanding these immune aspects is crucial for unraveling PD etiopathogenesis.
- Further research into neuroinflammation and autoimmunity may reveal novel therapeutic targets for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...